Universitäres Centrum für Tumorerkrankungen Mainz (UCT Mainz)
Klinisch orientierter Schwerpunkt / Johannes Gutenberg-Universität Mainz
Hinz, Andreas; Mehnert, Anja; Kocalevent, Rueya-Daniela et al.
Assessment of depression severity with the PHQ-9 in cancer patients and in the general populationBMC PSYCHIATRY. Bd. 16. 2016
Hoetker, Andreas M.; Mazaheri, Yousef; Aras, Oemer et al.
Assessment of Prostate Cancer Aggressiveness by Use of the Combination of Quantitative DWI and Dynamic Contrast-Enhanced MRIAMERICAN JOURNAL OF ROENTGENOLOGY. Bd. 206. H. 4. 2016 S. 756-763
Kabala, Matthias; Panholzer, Torsten
Aufbau einer gemeinsamen virtuellen Biomaterialbank an der Universitätsmedizin Mainz2016
Oh, Do-Youn; Lockhart, Albert C.; Wong, Deborah Jean Lee et al.
Avelumab (MSB0010718C), an anti-PD-L1 antibody, as a third-line treatment in patients with advanced gastric or gastroesophageal junction cancer: A phase Ib JAVELIN Solid Tumor trial.JOURNAL OF CLINICAL ONCOLOGY. Bd. 34. H. 4. 2016
Lisak, D.; Schacht, T.; Gawlitza, A. et al.
BAX inhibitor-1 is a Ca2+ channel critically important for immune cell function and survivalCELL DEATH AND DIFFERENTIATION. Bd. 23. H. 2. 2016 S. 358-368
Marme, F.; Grischke, E-M; Gropp-Meier, M. et al.
Biomarker results from PENELOPE, A randomised phase III trial evaluating chemotherapy (CT) +/- pertuzumab (P) for platinum-resistant ovarian cancer (PROC) with low tumor HER3 mRNA expressionONCOLOGY RESEARCH AND TREATMENT. Bd. 39. 2016 S. 94-94
Efferth, Thomas; Banerjee, Mita; Paul, Norbert W. et al.
Biopiracy of natural products and good bioprospecting practicePHYTOMEDICINE. Bd. 23. H. 2. 2016 S. 166-173
Goebeler, Maria-Elisabeth; Knop, Stefan; Viardot, Andreas et al.
Bispecific T-Cell Engager (BiTE) Antibody Construct Blinatumomab for the Treatment of Patients With Relapsed/Refractory Non-Hodgkin Lymphoma: Final Results From a Phase I StudyJOURNAL OF CLINICAL ONCOLOGY. Bd. 34. H. 10. 2016 S. 1104-+
Schmidt, L. H.; Kuemmel, A.; Schliemann, C. et al.
Blood group antigen A type 3 expression is a favorable prognostic factor in advanced NSCLCLUNG CANCER. Bd. 92. 2016 S. 8-14
Thomas, Christian; Spanidis, Magdalena; Engel, Christina et al.
Bone scintigraphy predicts bisphosphonate-induced osteonecrosis of the jaw (BRONJ) in patients with metastatic castration-resistant prostate cancer (mCRPC)CLINICAL ORAL INVESTIGATIONS. Bd. 20. H. 4. 2016 S. 753-758